Topics

Articles

mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year 

Deal provides ten23 with drug product development, biologic manufacturing experience

Biologics manufacturer to construct new C&GT facility to support expansion

Facility meets cGMP standards for radiopharmaceutical production

CDTMO’s fourth site further expands its support of cell therapy delivery and access 

Transaction enhances CDMO’s services when it comes to drug product offerings

Research collaboration centered around AAV capsids

Deal is expected to boost manufacturer’s European presence, Aceto executives say

Among areas, financial commitment will power clinical and commercial manufacturing suites

Company officials predict 500 million vaccine doses per year to be produced via the center, which will offer fill-finish, packaging services